Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation NY Valves 2024

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

June 05, 2024

News Daily News

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

Michael O'Riordan

May 07, 2024

Presentation TCT 2023

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Daijiro Tomii

October 26, 2023

News Daily News

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

Michael O'Riordan

September 27, 2023

News Daily News

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

L.A. McKeown

August 21, 2023

News Opinion CV Team Dispatch

July 2023 News Roundup

L.A. McKeown

July 01, 2023

Presentation

RAS Inhibition Following TAVR

July 29, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

Presentation TVT 2019

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Alexis Okoh

June 14, 2019

News Features ESC Heart Failure 2019

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

Shelley Wood

May 30, 2019

News Conference News ESC Heart Failure 2019

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

Shelley Wood

May 27, 2019

Presentation EuroPCR 2019

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Presenter: IJ. Amat-Santos

May 21, 2019

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

Recent Stroke Heightens Risk of Perioperative Events After AVR

Todd Neale

April 25, 2018

Advertisement

Renin-Angiotensin System Inhibition in Patients With Myocardial Injury Complicating Transcatheter Aortic Valve Replacement

SGLT2 Inhibitor Added to GDMT in Functional MR May Obviate Need for TEER

TCT 54: Renin-Angiotensin System Inhibition and Cardiac Damage in Patients Undergoing Transcatheter Aortic Valve Replacement

Medical Therapy ‘Disappointing’ Prior to TEER for Functional MR: TVT Registry

US and European Valvular Guidelines Mostly Concordant, Analysis Finds

July 2023 News Roundup

RAS Inhibition Following TAVR

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Renin-Angiotensin-Aldosterone System Inhibitors Are Associated With Reno-Protective Effects in Aging Patients Undergoing Transcatheter Aortic Valve Replacement

At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback

MitraClip Benefits FMR Patients Regardless of Baseline BNP: COAPT

Impact of Renin-Angiotensin System inhibition in patients following Transcatheter Aortic Valve Implantation: The multicenter RASTAVI study.

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Recent Stroke Heightens Risk of Perioperative Events After AVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content